285 related articles for article (PubMed ID: 20473306)
1. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
Nadig SN; Wieckiewicz J; Wu DC; Warnecke G; Zhang W; Luo S; Schiopu A; Taggart DP; Wood KJ
Nat Med; 2010 Jul; 16(7):809-13. PubMed ID: 20473306
[TBL] [Abstract][Full Text] [Related]
2. Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
Hester J; Schiopu A; Nadig SN; Wood KJ
Am J Transplant; 2012 Aug; 12(8):2008-16. PubMed ID: 22500984
[TBL] [Abstract][Full Text] [Related]
3. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.
Warnecke G; Bushell A; Nadig SN; Wood KJ
Transplantation; 2007 Jun; 83(11):1459-65. PubMed ID: 17565319
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Xia G; He J; Leventhal JR
Am J Transplant; 2008 Feb; 8(2):298-306. PubMed ID: 18190656
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
[TBL] [Abstract][Full Text] [Related]
6. Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.
Piloni D; Morosini M; Magni S; Balderacchi A; Scudeller L; Cova E; Oggionni T; Stella G; Tinelli C; Antonacci F; D'Armini AM; Meloni F
BMC Pulm Med; 2017 Jul; 17(1):102. PubMed ID: 28720146
[TBL] [Abstract][Full Text] [Related]
7. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA.
Engela AU; Hoogduijn MJ; Boer K; Litjens NH; Betjes MG; Weimar W; Baan CC
Clin Exp Immunol; 2013 Aug; 173(2):343-54. PubMed ID: 23607314
[TBL] [Abstract][Full Text] [Related]
8. CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.
Warnecke G; Feng G; Goto R; Nadig SN; Francis R; Wood KJ; Bushell A
Am J Pathol; 2010 Jul; 177(1):464-72. PubMed ID: 20472892
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
10. Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.
Berglund D; Karlsson M; Biglarnia AR; Lorant T; Tufveson G; Korsgren O; Carlsson B
Clin Exp Immunol; 2013 Aug; 173(2):310-22. PubMed ID: 23607776
[TBL] [Abstract][Full Text] [Related]
11. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
Issa F; Hester J; Goto R; Nadig SN; Goodacre TE; Wood K
Transplantation; 2010 Dec; 90(12):1321-7. PubMed ID: 21048528
[TBL] [Abstract][Full Text] [Related]
13. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
14. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.
Webster KE; Walters S; Kohler RE; Mrkvan T; Boyman O; Surh CD; Grey ST; Sprent J
J Exp Med; 2009 Apr; 206(4):751-60. PubMed ID: 19332874
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
Wu DC; Hester J; Nadig SN; Zhang W; Trzonkowski P; Gray D; Hughes S; Johnson P; Wood KJ
Transplantation; 2013 Oct; 96(8):707-16. PubMed ID: 23917725
[TBL] [Abstract][Full Text] [Related]
16. Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells.
Afzali B; Mitchell PJ; Scottà C; Canavan J; Edozie FC; Fazekasova H; Lord GM; John S; Barber LD; Hernandez-Fuentes MP; Lechler RI; Lombardi G
Am J Transplant; 2011 Aug; 11(8):1734-42. PubMed ID: 21749646
[TBL] [Abstract][Full Text] [Related]
17. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
Heim C; Bernhardt W; Jalilova S; Wang Z; Motsch B; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
Interact Cardiovasc Thorac Surg; 2016 May; 22(5):561-70. PubMed ID: 26819270
[TBL] [Abstract][Full Text] [Related]
18. Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.
Beyer M; Classen S; Endl E; Kochanek M; Weihrauch MR; Debey-Pascher S; Knolle PA; Schultze JL
Clin Dev Immunol; 2011; 2011():734036. PubMed ID: 21904560
[TBL] [Abstract][Full Text] [Related]
19. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients.
Chen M; Mohtize M; Matteï MF; Villemot JP; Kohler C; Faure GC; Béné MC; de Carvalho Bittencourt M
Clin Exp Immunol; 2011 Jan; 163(1):104-12. PubMed ID: 21039425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
